---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009727"
form_type: "8-K"
ticker: "NMRA"
cik: "0001885522"
company_name: "Neumora Therapeutics, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:57:24.705360+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Neumora Therapeutics furnishes corporate presentation for J.P. Morgan conference; full content not disclosed in filing

## Summary
- Corporate presentation made available under Item 7.01, not filed for SEC purposes.
- Presentation used at 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026.
- No specific pipeline, financial, or operational updates can be extracted from the filing or incomplete exhibit.
- Exhibit 99.1 was not fully provided, limiting assessment of material new information.

## SEC filing metadata
- accession: 0001193125-26-009727
- form_type: 8-K
- ticker: NMRA
- cik: 0001885522
- company_name: Neumora Therapeutics, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1885522/000119312526009727/0001193125-26-009727-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1885522/000119312526009727/d34054d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009727
- JSON: https://secwatch.observer/filing/0001193125-26-009727.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009727.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.